$3.11
0.00500.16%
Pre-Market: 7:06 AM EDT
15 minutes delayed
Petco Health and Wellness
WOOFNASDAQ
Petco Health and Wellness (NASDAQ:WOOF) Stock, Analyst Ratings, Price Targets, Predictions
Petco Health and Wellness Co Inc has a consensus price target of $7.43, established from looking at the 75 latest analyst ratings. The last 3 analyst ratings were released from Wedbush, RBC Capital, and Needham on May 29, 2024, May 24, 2024, and May 23, 2024. With an average price target of $4 between Wedbush, RBC Capital, and Needham, there's an implied 28.62% upside for Petco Health and Wellness Co Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Wedbush
RBC Capital
Needham
UBS
Citigroup
1calculated from analyst ratings
Analyst Ratings for Petco Health and Wellness
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/29/2024 | Buy Now | 28.62% | Wedbush | Seth Basham | $4 → $4 | Reiterates | Outperform → Outperform | Get Alert |
| 05/24/2024 | Buy Now | -3.54% | RBC Capital | Steven Shemesh | $2.7 → $3 | Maintains | Outperform | Get Alert |
| 05/23/2024 | Buy Now | 60.77% | Needham | Anna Andreeva | → $5 | Reiterates | Buy → Buy | Get Alert |
| 05/23/2024 | Buy Now | 28.62% | Wedbush | Seth Basham | $3 → $4 | Maintains | Outperform | Get Alert |
| 05/23/2024 | Buy Now | 4.5% | UBS | Michael Lasser | $2.5 → $3.25 | Maintains | Neutral | Get Alert |
| 05/07/2024 | Buy Now | -43.73% | Citigroup | Steven Zaccone | $2.85 → $1.75 | Maintains | Neutral | Get Alert |
| 04/02/2024 | Buy Now | -51.77% | B of A Securities | Elizabeth Suzuki | $5 → $1.5 | Downgrade | Buy → Underperform | Get Alert |
| 03/25/2024 | Buy Now | -35.69% | Wells Fargo | Zachary Fadem | $3 → $2 | Maintains | Equal-Weight | Get Alert |
| 03/20/2024 | Buy Now | -19.61% | UBS | Michael Lasser | $3 → $2.5 | Maintains | Neutral | Get Alert |
| 03/15/2024 | Buy Now | -13.18% | RBC Capital | Steven Shemesh | $3.5 → $2.7 | Maintains | Outperform | Get Alert |
| 03/15/2024 | Buy Now | -3.54% | Evercore ISI Group | Oliver Wintermantel | $4 → $3 | Maintains | In-Line | Get Alert |
| 03/14/2024 | Buy Now | -19.61% | Baird | Justin Kleber | $3 → $2.5 | Maintains | Neutral | Get Alert |
| 03/13/2024 | Buy Now | 60.77% | Needham | Anna Andreeva | $5 → $5 | Maintains | Buy | Get Alert |
| 12/19/2023 | Buy Now | — | Jefferies | Kaumil Gajrawala | → $3.11 | Initiates | → Hold | Get Alert |
| 12/04/2023 | Buy Now | -3.54% | Morgan Stanley | Simeon Gutman | $5 → $3 | Maintains | Equal-Weight | Get Alert |
| 12/04/2023 | Buy Now | 12.54% | RBC Capital | Steven Shemesh | $7 → $3.5 | Maintains | Outperform | Get Alert |
| 11/30/2023 | Buy Now | 60.77% | Goldman Sachs | Kate McShane | $7 → $5 | Maintains | Buy | Get Alert |
| 11/30/2023 | Buy Now | 12.54% | Wedbush | Seth Basham | $4.5 → $3.5 | Maintains | Outperform | Get Alert |
| 11/29/2023 | Buy Now | 60.77% | Needham | Anna Andreeva | $8 → $5 | Maintains | Buy | Get Alert |
| 11/29/2023 | Buy Now | — | Wells Fargo | Zachary Fadem | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/31/2023 | Buy Now | 44.69% | Wedbush | Seth Basham | $6 → $4.5 | Maintains | Outperform | Get Alert |
| 09/29/2023 | Buy Now | — | Wolfe Research | Greg Badishkanian | — | Initiates | → Peer Perform | Get Alert |
| 09/08/2023 | Buy Now | 157.23% | Evercore ISI Group | Oliver Wintermantel | $6 → $8 | Maintains | In-Line | Get Alert |
| 08/25/2023 | Buy Now | 221.54% | B of A Securities | Elizabeth Suzuki | $12 → $10 | Maintains | Buy | Get Alert |
| 08/25/2023 | Buy Now | 60.77% | Morgan Stanley | Simeon Gutman | $9 → $5 | Maintains | Equal-Weight | Get Alert |
| 08/25/2023 | Buy Now | 125.08% | RBC Capital | Steven Shemesh | $10 → $7 | Maintains | Outperform | Get Alert |
| 08/25/2023 | Buy Now | 92.93% | Wedbush | Seth Basham | $9 → $6 | Maintains | Outperform | Get Alert |
| 08/25/2023 | Buy Now | 125.08% | Wells Fargo | Zachary Fadem | $11 → $7 | Maintains | Overweight | Get Alert |
| 08/25/2023 | Buy Now | 157.23% | Needham | Anna Andreeva | $12 → $8 | Maintains | Buy | Get Alert |
| 08/16/2023 | Buy Now | 189.39% | Wedbush | Seth Basham | $10 → $9 | Maintains | Outperform | Get Alert |
| 05/26/2023 | Buy Now | 285.85% | B of A Securities | Elizabeth Suzuki | $14.5 → $12 | Maintains | Buy | Get Alert |
| 05/26/2023 | Buy Now | 221.54% | RBC Capital | Steven Shemesh | → $10 | Reiterates | Outperform → Outperform | Get Alert |
| 05/25/2023 | Buy Now | 189.39% | Morgan Stanley | Simeon Gutman | $10 → $9 | Maintains | Equal-Weight | Get Alert |
| 05/24/2023 | Buy Now | 285.85% | Needham | Anna Andreeva | $15 → $12 | Maintains | Buy | Get Alert |
| 05/22/2023 | Buy Now | 253.7% | Wedbush | Seth Basham | → $11 | Reiterates | Outperform → Outperform | Get Alert |
| 04/28/2023 | Buy Now | 221.54% | Gordon Haskett | Greg Sommer | → $10 | Initiates | → Hold | Get Alert |
| 04/14/2023 | Buy Now | 382.32% | Needham | Anna Andreeva | $20 → $15 | Maintains | Buy | Get Alert |
| 03/29/2023 | Buy Now | 366.24% | B of A Securities | Elizabeth Suzuki | $18 → $14.5 | Maintains | Buy | Get Alert |
| 03/28/2023 | Buy Now | 173.31% | Citigroup | Steven Zaccone | $11 → $8.5 | Maintains | Neutral | Get Alert |
| 03/23/2023 | Buy Now | 221.54% | Evercore ISI Group | Oliver Wintermantel | $12 → $10 | Maintains | In-Line | Get Alert |
| 03/23/2023 | Buy Now | 221.54% | RBC Capital | Steven Shemesh | $14 → $10 | Maintains | Outperform | Get Alert |
| 03/23/2023 | Buy Now | 221.54% | Morgan Stanley | Simeon Gutman | $12 → $10 | Maintains | Equal-Weight | Get Alert |
| 03/23/2023 | Buy Now | 253.7% | Baird | Justin Kleber | $14 → $11 | Maintains | Outperform | Get Alert |
| 03/23/2023 | Buy Now | 543.09% | Needham | Anna Andreeva | → $20 | Reiterates | → Buy | Get Alert |
| 03/15/2023 | Buy Now | 285.85% | Wells Fargo | Zachary Fadem | $14 → $12 | Maintains | Overweight | Get Alert |
| 03/13/2023 | Buy Now | 253.7% | Citigroup | Steven Zaccone | → $11 | Downgrade | Buy → Neutral | Get Alert |
| 02/09/2023 | Buy Now | 350.16% | RBC Capital | Steven Shemesh | → $14 | Reiterates | → Outperform | Get Alert |
| 01/17/2023 | Buy Now | 285.85% | Morgan Stanley | Simeon Gutman | $14 → $12 | Maintains | Equal-Weight | Get Alert |
| 12/02/2022 | Buy Now | 350.16% | Morgan Stanley | Simeon Gutman | $19 → $14 | Maintains | Equal-Weight | Get Alert |
| 12/01/2022 | Buy Now | 414.47% | Goldman Sachs | Kate McShane | $18 → $16 | Maintains | Buy | Get Alert |
| 12/01/2022 | Buy Now | 414.47% | RBC Capital | Steven Shemesh | $17 → $16 | Maintains | Outperform | Get Alert |
| 12/01/2022 | Buy Now | 285.85% | UBS | Michael Lasser | $16 → $12 | Maintains | Neutral | Get Alert |
| 11/28/2022 | Buy Now | 543.09% | Needham | Anna Andreeva | $30 → $20 | Maintains | Buy | Get Alert |
| 11/18/2022 | Buy Now | 350.16% | Wells Fargo | Zachary Fadem | $19 → $14 | Maintains | Overweight | Get Alert |
| 10/19/2022 | Buy Now | 285.85% | Evercore ISI Group | Oliver Wintermantel | $15 → $12 | Downgrade | Outperform → In-Line | Get Alert |
| 10/04/2022 | Buy Now | 478.78% | Goldman Sachs | Kate McShane | $20 → $18 | Maintains | Buy | Get Alert |
| 09/26/2022 | Buy Now | 510.93% | Wells Fargo | Zachary Fadem | $22 → $19 | Maintains | Overweight | Get Alert |
| 09/07/2022 | Buy Now | 446.62% | RBC Capital | Steven Shemesh | → $17 | Initiates | → Outperform | Get Alert |
| 08/25/2022 | Buy Now | 510.93% | Morgan Stanley | Simeon Gutman | $21 → $19 | Maintains | Equal-Weight | Get Alert |
| 08/12/2022 | Buy Now | 607.4% | Wells Fargo | Zachary Fadem | $27 → $22 | Maintains | Overweight | Get Alert |
| 07/26/2022 | Buy Now | 478.78% | Wedbush | Seth Basham | $25 → $18 | Maintains | Outperform | Get Alert |
| 06/27/2022 | Buy Now | 575.24% | Goldman Sachs | Kate McShane | $23 → $21 | Maintains | Buy | Get Alert |
| 05/25/2022 | Buy Now | 543.09% | Citigroup | Steven Zaccone | $26 → $20 | Maintains | Buy | Get Alert |
| 05/25/2022 | Buy Now | 575.24% | Baird | Peter Benedict | $25 → $21 | Maintains | Outperform | Get Alert |
| 05/16/2022 | Buy Now | 575.24% | Morgan Stanley | Simeon Gutman | → $21 | Initiates | → Equal-Weight | Get Alert |
| 05/13/2022 | Buy Now | 736.01% | Citigroup | Steven Zaccone | $28 → $26 | Maintains | Buy | Get Alert |
| 04/14/2022 | Buy Now | 800.32% | Citigroup | Steven Zaccone | $26 → $28 | Maintains | Buy | Get Alert |
| 03/29/2022 | Buy Now | 703.86% | Wedbush | Seth Basham | $23 → $25 | Maintains | Outperform | Get Alert |
| 12/16/2021 | Buy Now | 864.63% | Needham | Anna Andreeva | — | Initiates | → Buy | Get Alert |
| 12/06/2021 | Buy Now | 639.55% | Wedbush | Seth Basham | — | Upgrade | Neutral → Outperform | Get Alert |
| 11/19/2021 | Buy Now | 832.48% | Citigroup | — | — | Maintains | Buy | Get Alert |
| 11/15/2021 | Buy Now | — | Jefferies | Stephanie Wissink | — | Downgrade | Buy → Hold | Get Alert |
| 08/20/2021 | Buy Now | 800.32% | Credit Suisse | Lavesh Hemnani | — | Upgrade | Neutral → Outperform | Get Alert |
| 08/06/2021 | Buy Now | 671.7% | Jefferies | Stephanie Wissink | — | Initiates | → Buy | Get Alert |
| 07/16/2021 | Buy Now | 414.47% | BNP Paribas | — | — | Initiates | → Underperform | Get Alert |
FAQ
What is the target price for Petco Health and Wellness (WOOF) stock?
The latest price target for Petco Health and Wellness (NASDAQ:WOOF) was reported by Wedbush on May 29, 2024. The analyst firm set a price target for $4.00 expecting WOOF to rise to within 12 months (a possible 28.62% upside). 30 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Petco Health and Wellness (WOOF)?
The latest analyst rating for Petco Health and Wellness (NASDAQ:WOOF) was provided by Wedbush, and Petco Health and Wellness reiterated their outperform rating.
When was the last upgrade for Petco Health and Wellness (WOOF)?
The last upgrade for Petco Health and Wellness Co Inc happened on December 6, 2021 when Wedbush raised their price target to $23. Wedbush previously had a neutral for Petco Health and Wellness Co Inc.
When was the last downgrade for Petco Health and Wellness (WOOF)?
The last downgrade for Petco Health and Wellness Co Inc happened on April 2, 2024 when B of A Securities changed their price target from $5 to $1.5 for Petco Health and Wellness Co Inc.
When is the next analyst rating going to be posted or updated for Petco Health and Wellness (WOOF)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Petco Health and Wellness, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Petco Health and Wellness was filed on May 29, 2024 so you should expect the next rating to be made available sometime around May 29, 2025.
Is the Analyst Rating Petco Health and Wellness (WOOF) correct?
While ratings are subjective and will change, the latest Petco Health and Wellness (WOOF) rating was a reiterated with a price target of $4.00 to $4.00. The current price Petco Health and Wellness (WOOF) is trading at is $3.11, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.